← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Surgery Partners, Inc.: Revenue grew 6.2% to $3.309B from $3.114B. Net loss narrowed to $77.9M from $168M. Free cash flow declined 6.7% to $196M from $210M. Operating margin expanded 57 bps to 11.77%. Surgery Partners, Inc.'s annual comparison also shows free cash flow declined despite revenue growth; margins improved while free cash flow declined; inventory grew faster than revenue; the balance-sheet screen falls in the distress range and requires business-model context.
The read at a glance✓ Audited against SEC data
- Growth — Revenue grew 6.2% to $3.309B from $3.114BOK
- Profitability — Net loss narrowed to $77.9M from $168MOK
- Cash flow — Free cash flow declined 6.7% to $196M from $210MWatch
- Margins — Operating margin expanded 57 bps to 11.77%OK
- Accounting — Distress-range screen needs contextWatch
- Insiders — 0 purchases and 16 salesWatch
Business
We are dependent upon government and private insurance sources of payment for the services we provide.
Where the revenue comes from
Fiscal 2025, as Surgery Partners, Inc. reports it. History and quarterly detail are in the app.
- Patient service revenues$3.2B
- Other Services$82.4M
Leadership changes
From Surgery Partners, Inc.'s own filings, the day they're filed.
- Harrison R. Bane · President · departureeff. 2025-10-03
- Blair E. Hendrix · Chairman · departureeff. 2025-08-04
- Laura L. Forese · directors · appointment
Latest filings
- 8-K · Company announcement2026-08-10
- 10-Q · Quarterly report2026-08-10
- 8-K · Company announcement2026-07-24
- 8-K · Company announcement2026-06-05
- 8-K · Company announcement2026-05-05
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Surgery Partners, Inc., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.